Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
- :
Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice
After four weeks, the dose is typically increased to 0.5 mg weekly , and if further glycaemic control is needed, it may be increased to 1 mg weekly after at least another four weeks
The selectivity of the sensing system towards GSH detection over other amino acids and common components of metal ions was evaluated
US$ 20.87
US$ 28.22
US$ 21.97
